Ferozsons Laboratories Limited (PSX:FEROZ)
308.34
-0.20 (-0.06%)
At close: Mar 27, 2025
Ferozsons Laboratories Revenue
Ferozsons Laboratories had revenue of 4.73B PKR in the quarter ending December 31, 2024, with 22.24% growth. This brings the company's revenue in the last twelve months to 16.82B, up 15.84% year-over-year. In the fiscal year ending June 30, 2024, Ferozsons Laboratories had annual revenue of 15.85B with 38.38% growth.
Revenue (ttm)
16.82B
Revenue Growth
+15.84%
P/S Ratio
0.81
Revenue / Employee
8.87M
Employees
1,896
Market Cap
13.66B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 15.85B | 4.40B | 38.38% |
Jun 30, 2023 | 11.46B | 2.13B | 22.80% |
Jun 30, 2022 | 9.33B | 450.80M | 5.08% |
Jun 30, 2021 | 8.88B | 2.67B | 42.93% |
Jun 30, 2020 | 6.21B | 409.49M | 7.06% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 61.19B |
Abbott Laboratories (Pakistan) | 68.18B |
AGP Limited | 25.03B |
The Searle Company | 28.80B |
Highnoon Laboratories | 23.02B |
Shifa International Hospitals | 25.45B |
Citi Pharma | 13.19B |
Otsuka Pakistan | 3.37B |